These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6614953)

  • 1. Commentary: cortisone acetate administered orally in dermatologic therapy.
    Fine RM
    Arch Dermatol; 1983 Oct; 119(10):865-8. PubMed ID: 6614953
    [No Abstract]   [Full Text] [Related]  

  • 2. Update on the dermatologic use of systemic glucocorticosteroids.
    Jackson S; Gilchrist H; Nesbitt LT
    Dermatol Ther; 2007; 20(4):187-205. PubMed ID: 17970885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative study of ocular side effects of pulse steroid therapy versus long-term oral steroid therapy in steroid responsiveness dermatoses.
    Dogra A; Jain M; Bajwa GS; Aggarwal A
    Int J Lepr Other Mycobact Dis; 2002 Sep; 70(3):213-4. PubMed ID: 12483972
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimizing complications from systemic glucocorticosteroid use.
    Nesbitt LT
    Dermatol Clin; 1995 Oct; 13(4):925-39. PubMed ID: 8785896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The hypothalamus-neurohypophysis-adrenal cortex system in prolonged corticosteroid therapy].
    Bogdanovich NK; Fleĭshman EV
    Arkh Patol; 1966; 28(4):18-24. PubMed ID: 6000323
    [No Abstract]   [Full Text] [Related]  

  • 6. [Corticosteroid therapy in multiple sclerosis. Comment on the letter by M. Haupts et al].
    Hohlfeld R; Engelhardt D
    Nervenarzt; 1994 Feb; 65(2):148. PubMed ID: 8164771
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion.
    Straub RH; Pongratz G; Schölmerich J; Kees F; Schaible TF; Antoni C; Kalden JR; Lorenz HM
    Arthritis Rheum; 2003 Jun; 48(6):1504-12. PubMed ID: 12794817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of the hypothalamic-pituitary-adrenal system of pigeons (Columba livia domestica) to suppression by dexamethasone, cortisol, and prednisolone.
    Westerhof I; Van den Brom WE; Mol JA; Lumeij JT; Rijnberk A
    Avian Dis; 1994; 38(3):435-45. PubMed ID: 7832695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the hypothalamo-pituitary-adrenal axis in patients on long-term glucocorticoid therapy: the short synacthen versus the insulin tolerance test.
    Kane KF; Emery P; Sheppard MC; Stewart PM
    QJM; 1995 Apr; 88(4):263-7. PubMed ID: 7796076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednicarbate after different forms of administration. Plasma levels of drug and metabolites and effects on endogenous cortisol levels in humans.
    Barth J; Hochhaus G; Derendorf H; Lehr KH; Höhler T; Moellmann H
    Curr Probl Dermatol; 1993; 21():147-56. PubMed ID: 8299368
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of adenosine on the hypothalamo-hypophyseal-adrenal system].
    Kononenko VIa; Pil'kevych LI
    Fiziol Zh (1994); 1994; 40(5-6):20-3. PubMed ID: 8521985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in glucocorticoid therapy.
    Baxter JD
    Adv Intern Med; 2000; 45():317-49. PubMed ID: 10635054
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of dermatitis and toxicodermia with prednisolone and prednisolone ointment].
    Lipets ME
    Sov Med; 1967 Jan; 30(1):138-41. PubMed ID: 5611311
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinico-therapeutic experiences with the chronopluricorticoid drug Dutimelan 8-15 in dermatologic patients].
    Pomi M
    G Ital Dermatol Venereol; 1982; 117(1):I-IV. PubMed ID: 6764755
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral vs parenteral corticosteroids: a clinical controversy.
    Rees RB
    J Am Acad Dermatol; 1981 Nov; 5(5):602-4. PubMed ID: 7298927
    [No Abstract]   [Full Text] [Related]  

  • 16. Uses, adverse effects of abuse of corticosteroids. Part II.
    Imam AP; Halpern GM
    Allergol Immunopathol (Madr); 1995; 23(1):2-15. PubMed ID: 7631589
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment modalities and hypothalamo-pituitary-adrenal (HPA) axis suppression in Japanese patients with asthma].
    Hasegawa T; Ishihara K; Matsumoto H; Tomioka H; Okazaki M; Katakami N; Sakamoto H; Umeda B; Katayama S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Aug; 32(8):757-62. PubMed ID: 7807754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents.
    Mahachoklertwattana P; Vilaiyuk S; Hongeng S; Okascharoen C
    J Pediatr; 2004 Jun; 144(6):736-40. PubMed ID: 15192618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of the HPA axis in pediatric patients with atopic dermatitis.
    Ishay A; Ziv M; Kerner M; Luboshitzky R
    Arch Dermatol; 2007 Nov; 143(11):1449-50. PubMed ID: 18025377
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypothalamic-pituitary-adrenal-glucocorticoid axis function in rheumatoid arthritis.
    Masi AT; Chrousos GP
    J Rheumatol; 1996 Apr; 23(4):577-81. PubMed ID: 8730107
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.